Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...
Analyst Tom Nikic from Needham reiterated a Buy rating on On Holding AG (ONON – Research Report) and keeping the price target at $64.00.Stay ...
Celsius (NASDAQ:CELH – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & ...
Analyst Gil Blum from Needham maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) and keeping the price target at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback